AGEN FY2022 SEC EDGAR DEF 14A

Agenus Inc CEO pay ratio

The CEO earned $5.6M in FY2022 against median worker pay of $112,526 · Chemicals & Pharmaceuticals.

State
DE
Filing date
2023-04-28
Industry
Chemicals & Pharmaceuticals
Fiscal year
FY2022

Data updated August 2026

Subscribe to Agenus Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
50:1
Below Average (Scale: 0–1000:1)
CEO pay
$5.6M
Median worker
$112,526

Latest filing FY2022. This company's newest DEF 14A on file is for FY2022, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.

Answer first

Agenus Inc reported a 50:1 CEO-to-worker pay ratio in FY2022 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
50:1
FY2022 disclosed
CEO total
$5.6M
Summary Compensation Table total
Median worker
$112,526
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2022

A component-level pay breakdown is not reported in Agenus Inc's structured SEC pay-ratio disclosure. See our methodology →

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
50:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.6M
Companies in Industry
168
vs. Industry Median
Above

Agenus Inc: MODEST · MID$ pay ratio

Agenus Inc disclosed 50:1 CEO-to-worker pay and $5.6M CEO total in FY2022. the CEO earned 50× the median employee ($112,526) in FY2022.

Median employee $112,526 (HIGH-MED); MODEST · MID$ stamps put about 50 median-wage years per CEO year.

CEO Total Pay

$5.6M

FY2022 Summary Compensation, below median

Pay Ratio

50:1

Below typical

What FY2022 shows for Agenus Inc

Agenus Inc disclosed 50:1 CEO-to-worker pay and $5.6M CEO total in FY2022. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Agenus Inc's $5.6M CEO total is at or below the $7.9M industry median CEO pay.

Agenus Inc stamps MODEST · MID$ · HIGH-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2022

Total Compensation
$5.6M
Median Employee Pay
$112,526
Pay Ratio
50:1
Filing Date
2023-04-28

Company Info

Ticker
AGEN
CIK
1098972
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
SEC EDGAR DEF 14A for CIK 1098972, FY2022. Informational only, not investment advice. Verify on EDGAR.

Read with Agenus Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · HIGH-MED.

Data sourced from SEC EDGAR DEF 14A for Agenus Inc (CIK 1098972), FY2022. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.